DNA-based supercomputer can run 100 billion parallel programs

The boundaries of computer technology are being redefined as biology merges with electronics. At the forefront of this evolution lies a liquid computer powered by DNA.

DNA-based programmable gate arrays could revolutionize medical diagnostics and computing

DNA-based programmable gate arrays could revolutionize medical diagnostics and computing. (CREDIT: CC BY-SA 4.0)

The boundaries of computer technology are being redefined as biology merges with electronics. At the forefront of this evolution lies an innovative concept—a liquid computer powered by DNA. With the capacity to support over 100 billion unique circuits, this revolutionary system might soon reshape medical diagnostics and disease detection.

DNA, known as the foundation of life, carries the genetic code for all living organisms. However, a research team led by Dr. Fei Wang at Shanghai Jiao Tong University is exploring DNA's potential as a computational element.

Their research was recently published in the journal Nature. In their vision, DNA molecules act not just as the carriers of genetic information but also as wires, instructions, and even electrons within computer circuits.

In traditional computers, electrons follow predefined paths on silicon chips to execute commands. The more complex the operation, the more intricate the pathways. Dr. Wang’s team, however, sought a biological alternative to traditional silicon-based design.

They explored how short DNA segments could combine into larger molecular structures capable of functioning as circuit components. These structures could serve as wires or even guide molecular wiring for stable connections.

Uniform dual-rail computing units with logic-gated DNA–UTS transmission. (CREDIT: Nature)

The researchers filled test tubes with DNA strands suspended in a buffer fluid, enabling them to interact and form complex molecules through chemical reactions. Fluorescent markers embedded in these molecules allowed scientists to monitor the activity of the DNA circuits by observing the glowing parts.

The Rise of DNA-Based Programmable Arrays

The cornerstone of this innovation lies in DNA-based programmable gate arrays (DPGA). These programmable arrays, assembled from single-stranded DNA oligonucleotides, allow for highly scalable and adaptable circuits. Each DPGA supports over 100 billion unique configurations, allowing scientists to customize its functionality by introducing specific short molecules.

In one experiment, the team connected three DPGAs, using approximately 500 DNA strands, to build a circuit capable of solving quadratic equations. Another circuit was designed to calculate square roots. Input molecules interacted with the DNA circuit much like electrons travel through wires in conventional electronics. The resulting chemical reactions produced output molecules whose fluorescent glow allowed researchers to decode the results.

This innovative approach draws inspiration from field-programmable gate arrays (FPGAs) in silicon-based computing. FPGAs enable reconfiguration of circuits for diverse applications. Similarly, DPGAs offer programmability and scalability but operate within liquid-phase environments.

Unlike traditional circuits, where electrons move directionally, biomolecular components in liquid DNA systems diffuse and mix randomly, posing unique challenges. The researchers overcame these hurdles by introducing spatial compartmentalization to enhance directionality and scalability.

Revolutionizing Medical Diagnostics

While mathematical computations demonstrate the potential of DNA-based computing, its most transformative application lies in medical diagnostics.

Dr. Wang’s team developed a DPGA capable of distinguishing between different small RNA molecules, including those associated with renal cancer. This achievement underscores the potential for DNA computing in detecting disease at the molecular level.

Schematic workflow of DPGA programming. (CREDIT: Nature)

DNA’s inherent compatibility with biological systems makes it a natural fit for medical diagnostics. “DPGA-based diagnostic devices would be highly parallel and energy-efficient,” Dr. Wang explained. By harnessing DNA’s ability to interact with biological molecules, these circuits can perform intelligent diagnostics, identifying disease markers in complex biological samples.

For example, the team’s diagnostic circuit processed molecular inputs from RNA samples and identified the presence of cancer-related molecules through chemical reactions. The results were encoded in fluorescent signals, offering a straightforward method for detection. This capability positions DNA circuits as tools for real-time disease monitoring and personalized medicine.

Despite the groundbreaking achievements, DNA computing remains in its early stages. Challenges such as random molecular collisions and scalability limitations need to be addressed. Current DNA systems, while programmable, require further refinement to match the versatility of electronic circuits.

However, the potential applications are vast. DNA circuits could revolutionize healthcare by enabling seamless disease detection. Imagine a diagnostic device capable of identifying diseases from a simple blood or saliva sample based on the glow of molecules. This technology could pave the way for minimally invasive, efficient, and accurate diagnostics, transforming medical practices worldwide.

Outline of the design strategy for general-purpose DICs. (CREDIT: Nature)

Dr. Wang remains optimistic about the future of DNA computing. He envisions a time when DPGA technology will enable intelligent diagnostic tools embedded within living systems. Such advancements could detect diseases at their earliest stages, offering unprecedented opportunities for intervention.

A Glimpse into the Future

The convergence of biology and electronics offers a glimpse into the future of computing and healthcare. As scientists continue to push the boundaries of DNA computing, its applications may extend beyond medicine to fields such as environmental monitoring, synthetic biology, and artificial intelligence.

This innovative technology represents a paradigm shift in computation, leveraging the properties of DNA to solve complex problems in ways traditional systems cannot. With continued research, DNA-based programmable arrays could redefine the landscape of diagnostics, computation, and beyond.

Dr. Wang’s work exemplifies the transformative potential of interdisciplinary research. By combining principles of biology, chemistry, and computer science, his team has opened new avenues for innovation.

As the technology matures, its impact could be profound, offering solutions to some of humanity’s most pressing challenges.

Note: Materials provided above by The Brighter Side of News. Content may be edited for style and length.


Like these kind of feel good stories? Get The Brighter Side of News' newsletter.


Joseph Shavit
Joseph ShavitSpace, Technology and Medical News Writer
Joseph Shavit is the head science news writer with a passion for communicating complex scientific discoveries to a broad audience. With a strong background in both science, business, product management, media leadership and entrepreneurship, Joseph possesses the unique ability to bridge the gap between business and technology, making intricate scientific concepts accessible and engaging to readers of all backgrounds.